000 01561 a2200421 4500
005 20250516082000.0
264 0 _c20130726
008 201307s 0 0 eng d
022 _a1559-131X
024 7 _a10.1007/s12032-012-0197-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGhosn, M
245 0 0 _aSequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_cDec 2012
300 _a2831-7 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aOrganoplatinum Compounds
_xadministration & dosage
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aProspective Studies
650 0 4 _aGemcitabine
700 1 _aSaroufim, A
700 1 _aKattan, J
700 1 _aChahine, G
700 1 _aNasr, F
700 1 _aFarhat, F
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 29
_gno. 4
_gp. 2831-7
856 4 0 _uhttps://doi.org/10.1007/s12032-012-0197-9
_zAvailable from publisher's website
999 _c21598439
_d21598439